Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer

NCT03733210 is registered in ClinicalTrials.gov with Andrei Iagaru as lead sponsor.

NCT NCT03733210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer
Lead sponsor
Andrei Iagaru
Phase
Phase 1
Overall status
Completed
Start date
January 7, 2019
Completion date
August 9, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of the head and neck, squamous cell carcinoma of the head and neck